The Gut Microbiome and Butyrate Differentiate Clostridioides difficile Colonization and Infection in Children - Takeaways - MDSpire

The Gut Microbiome and Butyrate Differentiate Clostridioides difficile Colonization and Infection in Children

  • By

  • Maribeth R Nicholson

  • Siyuan Ma

  • Britton A Strickland

  • Mia Cecala

  • Lisa Zhang

  • Seth Reasoner

  • Emma R Guiberson

  • Matthew J Munneke

  • Meghan H Shilts

  • Eric P Skaar

  • Suman R Das

  • December 11, 2025

  • 0 min

Share

  • 1

    Clostridioides difficile can cause significant morbidity, with asymptomatic colonization occurring without symptoms in pediatric patients.

  • 2

    The study compared gut microbiota and butyrate levels in children with symptomatic CDI and asymptomatic colonization to understand disease mechanisms.

  • 3

    Symptomatic CDI was associated with increased levels of Escherichia/Shigella and decreased levels of beneficial gut microbes like Faecalibacterium.

  • 4

    Butyrate producers and fecal butyrate levels were significantly lower in symptomatic CDI patients compared to those with asymptomatic colonization.

  • 5

    The findings suggest that gut microbiota and butyrate may play a crucial role in distinguishing between asymptomatic colonization and symptomatic CDI.

Original Source(s)

The Gut Microbiome and Butyrate Differentiate Clostridioides difficile Colonization and Infection in Children

  • by Maribeth R Nicholson, Siyuan Ma, Britton A Strickland, Mia Cecala, Lisa Zhang, Seth Reasoner, Emma R Guiberson, Matthew J Munneke, Meghan H Shilts, Eric P Skaar, Suman R Das

  • December 11, 2025

Related Content

Manufacturability is access: redesigning antibody production for equitable pediatric access in LMICs

FDA Monthly Preview: Key June Decisions to Watch

Several FDA decisions across multiple specialties are expected this month.

Early ICU Rehab Backed, With Caveats

Invited narrative review supports early, interprofessional rehabilitation across the ICU recovery continuum while emphasizing heterogeneous evidence and inconsistent implementation worldwide.